simendan has been researched along with Muscle Contraction in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isbary, S; Johannsen, S; Roewer, N; Schuster, F; Türkmeneli, I | 1 |
| Alvarez, J; Brito, D; Farmakis, D; Fedele, F; Fonseca, C; Gal, TB; Gordon, AC; Gotsman, I; Grossini, E; Guarracino, F; Harjola, VP; Hellman, Y; Heunks, L; Ivancan, V; Karavidas, A; Kivikko, M; Lomivorotov, V; Longrois, D; Masip, J; Metra, M; Morelli, A; Nikolaou, M; Papp, Z; Parissis, J; Parkhomenko, A; Poelzl, G; Pollesello, P; Ravn, HB; Rex, S; Ricksten, SE; Riha, H; Schwinger, RHG; Vrtovec, B; Yilmaz, MB; Zielinska, M | 1 |
| Dekhuijzen, PN; Heunks, LM; van Hees, HW | 1 |
| Andrade Acuña, G; Dekhuijzen, PN; Heunks, LM; Linkels, M; van Hees, HW | 1 |
| Fox, CJ; Kaye, AD; Liu, H; Zhang, S | 1 |
| Erdem, A; Tandogan, I; Yalta, K; Yilmaz, MB; Yontar, OC | 1 |
| Angus, JA; Crack, PJ; Royse, CF; Soeding, PF; Wright, CE | 1 |
| Beck, J; Doorduin, J; Heunks, LM; Sinderby, CA; Stegeman, DF; van der Hoeven, JG; van Hees, HW | 1 |
| Gea, J | 1 |
| Nacitarhan, C; Seyrek, M; Yildiz, O | 1 |
| Hegedus, Z; Krassói, I; Kun, A; Papp, JG; Pataricza, J; Szolnoky, J; Varró, A | 1 |
| Papp, JG; Udvary, E; Végh, A | 1 |
| Gasser, R; Holzmann, S; Klein, W; Köppel, H; Pilger, E | 1 |
2 review(s) available for simendan and Muscle Contraction
| Article | Year |
|---|---|
Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.
Topics: Acute Disease; Anti-Arrhythmia Agents; Cardiotonic Agents; Clinical Trials as Topic; Expert Testimony; Heart; Heart Failure; Humans; Hydrazones; Muscle Contraction; Pyridazines; Simendan; Treatment Outcome | 2016 |
Cardiovascular pharmacology: an update.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Diastole; Heart Failure; Humans; Hydrazones; Muscle Contraction; Myofibrils; Natriuretic Peptide, Brain; Nicardipine; Pyridazines; Pyridines; Sarcomeres; Simendan; Urea | 2010 |
2 trial(s) available for simendan and Muscle Contraction
| Article | Year |
|---|---|
Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.
Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Female; Heart Conduction System; Heart Failure; Humans; Hydrazones; Male; Muscle Contraction; Pyridazines; Simendan; Statistics, Nonparametric | 2010 |
The calcium sensitizer levosimendan improves human diaphragm function.
Topics: Adult; Cross-Over Studies; Diaphragm; Double-Blind Method; Female; Humans; Hydrazones; Male; Muscle Contraction; Muscle Weakness; Phosphodiesterase Inhibitors; Pyridazines; Respiratory Function Tests; Simendan; Young Adult | 2012 |
9 other study(ies) available for simendan and Muscle Contraction
| Article | Year |
|---|---|
In vitro effects of levosimendan on muscle of malignant hyperthermia susceptible and non-susceptible swine.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Phosphodiesterase 3 Inhibitors; Simendan; Swine | 2018 |
Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease.
Topics: Aged; Cardiotonic Agents; Comorbidity; Diaphragm; Dose-Response Relationship, Drug; Female; Humans; Hydrazones; In Vitro Techniques; Lung Neoplasms; Male; Middle Aged; Muscle Contraction; Muscle Proteins; Myosin Heavy Chains; Pulmonary Disease, Chronic Obstructive; Pyridazines; Simendan | 2009 |
Levosimendan improves calcium sensitivity of diaphragm muscle fibres from a rat model of heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Diaphragm; Heart Failure; Humans; Hydrazones; Male; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Weakness; Myosin Heavy Chains; Pyridazines; Rats; Rats, Wistar; Simendan | 2011 |
Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1/2 activation.
Topics: Adrenergic beta-Agonists; Apoptosis; Caspase 3; Cell Hypoxia; Cytochromes c; Enzyme Activation; Heart Atria; Humans; Hydrazones; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoproterenol; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Contraction; Myocardium; Oxygen; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyridazines; Simendan | 2011 |
A drug therapy for muscle dysfunction in respiratory disorders?
Topics: Diaphragm; Female; Humans; Hydrazones; Male; Muscle Contraction; Muscle Weakness; Phosphodiesterase Inhibitors; Pyridazines; Simendan | 2012 |
Potassium channels in the vasodilating action of levosimendan on the human umbilical artery.
Topics: Cardiotonic Agents; Female; Humans; Hydrazones; Muscle Contraction; Muscle, Smooth; Placental Circulation; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Potassium Channels, Voltage-Gated; Pregnancy; Pyridazines; Simendan; Umbilical Arteries; Vasodilation | 2006 |
Vasorelaxing effect of levosimendan against 5-hydroxytryptamine-induced contractions in isolated human conduit bypass grafts.
Topics: Aged; Humans; Hydrazones; In Vitro Techniques; Isometric Contraction; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Pyridazines; Serotonin; Serotonin Antagonists; Simendan; Thoracic Arteries; Vasodilator Agents | 2006 |
Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
Topics: Analysis of Variance; Animals; Aorta; Cardiac Pacing, Artificial; Cardiotonic Agents; Disease Models, Animal; Dogs; Electrodes, Implanted; Female; Heart Failure; Hemodynamics; Hydrazones; Male; Muscle Contraction; Muscle, Smooth, Vascular; Pyridazines; Simendan; Ventricular Function, Left | 1995 |
Minimal effects of levosimendan on coronary artery smooth muscle tone.
Topics: Animals; Calcium; Cardiotonic Agents; Cattle; Coronary Vessels; Hydrazones; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Pyridazines; Simendan; Time Factors | 1999 |